Answers are grounded in this paper and cite their sources.
Cohort study demonstrates weight reduction with semaglutide in patients with obesity and overweight, suggesting effectiveness in chronic weight management.
Real-world use of semaglutide was associated with reductions in weight and BMI and improvement in cardiometabolic risk factors at 24 months among patients with obesity or overweight. These findings support the use of semaglutide in clinical practice as an effective treatment for chronic weight management.
No takes yet. Share an insight, caveat, or question.
Ruseva et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: